Identification of CD141+vasculogenic precursor cells from human bone marrow and their endothelial engagement in the arteriogenesis by co-transplantation with mesenchymal stem cells
Dual-cell therapy using BM-derived CD141<sup>+</sup> VPCs and BM-MSCs holds potential for further development in clinical trials to treat peripheral artery disease and diabetic ulcers.
Authors
- Gabee Park
- Seonmin Hong
- Dae Yeon Hwang (ORCID: https://orcid.org/0000-0001-6840-5790)
- Hyun Sook Hong
- Youngsook Son (ORCID: https://orcid.org/0000-0003-1656-0056)
- E. Lee
- Ji‐Young Han (ORCID: https://orcid.org/0000-0002-2364-8366)
- Jeong Seop Park (ORCID: https://orcid.org/0000-0002-3574-5649)
- Do Young Kim (ORCID: https://orcid.org/0000-0002-0194-9854)
- Dae Wook Kim (ORCID: https://orcid.org/0000-0003-0832-2808)
- Heedon Hwang
- Sung Vin Yim
Institutions
- Kyung Hee University (KR)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1186/s13287-024-03994-9
- Citations
- 4
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Ministry of Health and Welfare
- Ministry of Science and ICT, South Korea
- Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles